Proposta de adaptação de acompanhamento farmacoterapêutico com base nos métodos de Dáder, Minnesota e na realidade encontrada no atendimento de neurologia do CIS.
Article Sidebar
Main Article Content
Abstract
The pharmacotherapeutic follow-up is classified as one of the exclusive pharmaceutical care activities, being a practice that contributes with several benefits to the patient’s therapy, mainly enabling the identification of problems related to medications, which can negatively affect the life quality of an individual. The most commonly used classical methods are the Dáder method and the Minnesota model, therefore, the present study aims to evaluate them and offer a new model based on both, that will be more appropriate to the reality of neurology patients being currently treated at the Integrated Health Center (CIS) of the Anhembi Morumbi University. Pharmacists use methods that are based on both these models in order to collect the same kind of information about their patients, however, these methods have a few differences between each other when compared, being the Dáder method a more detailed one, divided in more phases, therefore, providing a better understanding to initiate this type of practice, with a greater focus on medication-related problems, and the Minnesota model attends with less phases, therefore, considered by many professionals with experience in the field, to be more practical to attend the service, also known to be a detailed method that considers all the possible problems regarding the patient’s therapy. Through the analysis of the adapted methods used by professionals at CIS, carried out during a six-month period, it is possible to observe the need for a method that would better attend the neurology patients, so that a more efficient service could be offered to them, that would optimize time and would attend all their necessitites, thus, the addapted method proposed in this study was developed with the purpose of further improving the quality of life of the patientes assisted at CIS.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Statement - Policy Proposal for Open Access Journals
Authors who publish in The Brazilian journal of Biomedical Sciences (RBCBM) agree to the following terms: 1 - Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License allowing sharing of the work with recognition of the authorship of the work and initial publication in this journal. 2 - Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. 3 - Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and citation of published work.
This is an open access article under the CC-BY license
(http://creativecommons.org/licenses/by/4.0)
References
Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy [Internet]. 2004;24(11):1491–8. Available from: file:///C:/Users/karol/Downloads/pharmaceutical care.pdf
Pereira LRL, Freitas O de. A evolução da Atenção Farmacêutica e a perspectiva para o Brasil. Rev Bras Ciências Farm [Internet]. 2008 Dec [cited 2020 Apr 17];44(4):601–12. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-93322008000400006&lng=pt&nrm=iso&tlng=pt
Machuca M, Fernández-Llimós F, Faus MJ. Método Dáder. Manual de Acompanhamento Farmacoterapêutico [Internet]. GIAF-UGR. Granada; 2004. 45 p. Available from: http://www.pharmanet.com.br/atencao/metododader.pdf
Becerra C. J, Martinez M. F, Bohorquez C. M, Guevarau U. ML, Ramirez N. E. Validation of a methodology for inpatient pharmacotherapy follow-up. Vitae [Internet]. 2012;19(3):261–9. Available from: http://www.scielo.org.co/pdf/vitae/v19n3/v19n3a4.pdf
Lopéz Ortega IL, Rosés Miguel Ernesto V. Drug related problems associated with the psychoactive drugs used on geriatric, hospitalized patients. Artic Brazilian J Pharm Sci [Internet]. 2012;48(3). Available from: http://www.scielo.br/pdf/bjps/v48n3/a12v48n3.pdf
DN O, FA N, AM N, WT H. The Disease Burden and the Extent of Drug Therapy Problems in an Underserved Minority Population Receiving Medication Therapy Management at an Ambulatory Care Free Clinic. J Pharm Care Heal Syst [Internet]. 2016;3(2). Available from: https://www.longdom.org/open-access/the-disease-burden-and-the-extent-of-drug-therapy-problems-in-anunderserved-minority-population-receiving-medication-therapymanage-2376-0419-1000157.pdf
BRASIL. Resolução RDC nº 338, de 06 de maio de 2004. Aprova a "Política Nacional de Assistência Farmacêutica" constante do anexo desta resolução. Órgão emissor: MS - Ministério da Saúde. Disponível em: https://www.siteal.iiep.unesco.org/sites/default/files/sit_accion_files/6390.pdf.
Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, et al. Effectiveness of Dader Method for Pharmaceutical Care on Control of Blood Pressure and Total Cholesterol in Outpatients with Cardiovascular Disease or Cardiovascular Risk: EMDADER-CV Randomized Controlled Trial. J Manag Care Spec Pharm [Internet]. 2012;18(4):311–23. Available from: https://pubmed.ncbi.nlm.nih.gov/22548691/
Sala Brune MFS, Ferreira EE, Ferrari CKB. O Método Dáder na atenção farmacêutica em pacientes hipertensos no município de Pontal do Araguaia-MT, Brasil. Mundo da Saude [Internet]. 2014;38(4):402–9. Available from: http://www.saocamilo-sp.br/pdf/mundo_saude/155566/A05.pdf
Colli Mattos LF, Napolitano PV. Pharmaceutical Care in Homeopathic Treatment. J Pharm Pharmacol [Internet]. 2018;6:106–12. Available from: https://davidpublisher.org/Public/uploads/Contribute/5a45f51107530.pdf
Martins BCC, Firmino PYM, Alves S de CF, Lima LF, Oliveira BE, Porto AC, et al. Adesão ao tratamento para hipertensão em uma unidade Básica de Saúde do Ceará - Adherence to treatment for hypertension in a Basic Health Unit of Ceará. Rev Bras Hipertens [Internet]. 2014;21(1):24–30. Available from: http://fi-admin.bvsalud.org/document/view/gg4xh
Ospina AS, Amariles P, Hincaopié-García JA, González-Avendaño S, M. Benjumea D, Faus MJ, et al. Effectiveness of the Dader Method for Pharmaceutical Care on Patients with Bipolar I Disorder: Results from the EMDADER-TAB Study. J Manag Care Spec Pharm [Internet]. 2017;23(1):74–84. Available from: https://www.jmcp.org/
Maracle HL, Ramalho de Oliveira D, Brummel A. Primary Care Providers ’ experiences with Pharmaceutical Care-based Medication Therapy Management Services. Inov Pharm [Internet]. 2012;3(1). Available from: https://pubs.lib.umn.edu/index.php/innovations/article/view/255/249
Lopes AR V., de Miranda SS, B. Ceccato MDG, R. Silveira M, H. de Resende N, S. Carvalho W. Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic , Minas Gerais , Brazil. Ann Brazilian Acad Sci [Internet]. 2017;89:2911–9. Available from: https://www.scielo.br/pdf/aabc/v89n4/0001-3765-aabc-89-04-02911.pdf
Detoni KB, Oliveira I V., Nascimento MMG, Caux TR, Alves MR, Ramalho de Oliveira D. Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease. Int J Clin Pharm [Internet]. 2016; Available from: https://pubmed.ncbi.nlm.nih.gov/27915426/
FERREIRA VL, MELO MLS. A IMPORTÂNCIA DO SEGUIMENTO FARMACOTERAPÊUTICO NA SAÚDE: UMA REVISÃO DA LITERATURA. Visão Acadêmica. 2016;17:125–38.
Amarante LC, Shoji LS, Freitas KM, Rascado RR, Silva LC, Marques LAM. Propuesta de adaptación de la hoja de historia farmacoterapéutica del método Dáder para aprendices. Rev Cuba Farm [Internet]. 2012;46(2):224–39. Available from: https://www.medigraphic.com/pdfs/revcubfar/rcf-2012/rcf122j.pdf
Lima de Meneses AL, Barreto Sá ML. Atençao Farmacêutica ao idosos: fundamentos e propostas. Geriatr Gerontol [Internet]. 2010;4(3):154–61. Available from: https://cdn.publisher.gn1.link/ggaging.com/pdf/v4n3a07.pdf
Nusair MB, Guirguis LM. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy. Res Soc Adm Pharm [Internet]. 2017 Mar 1;13(2):349–57. Available from: file:///C:/Users/karol/Downloads/nusair2016.pdf
Mendonça S de AM, De Freitas EL, De Oliveira DR. Competencies for the provision of comprehensive medication management services in an experiential learning project. PLoS One [Internet]. 2017;12(9):1–14. Available from: file:///C:/Users/karol/Downloads/10.1371@journal.pone.0185415.pdf
Nitrini R. A Neurologia: uma grande especialidade [Internet]. Vol. 91, Rev Med (São Paulo). 2012. Available from: file:///C:/Users/karol/Downloads/59012-Texto do artigo-75805-1-10-20130718.pdf
Pereira Da Silva L, Spegiorin MF, Brune S. ACOMPANHAMENTO FARMACOTERAPÊUTICO PELO MÉTODO DÁDER EM PACIENTES DIABÉTICOS. Rev Panorâmica [Internet]. 2018; Available from: file:///C:/Users/karol/Downloads/840-19192244-1-SM (4).pdf
de Vasconcelos RLH, dos Santos WRP, Sousa AML, Leal LH de C, Rezende Júnior LM, Reis JA da S, et al. Seguimento farmacoterapêutico de pacientes em tratamento com talidomida em um centro especializado em hanseníase. Sci Med (Porto Alegre) [Internet]. 2017;27(4). Available from: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-876944
García-Méndez L, María D, Jiménez-Méndez G. Enfermedades neurometabólicas: Orientación diagnóstica a partir de la clínica neurológica. Pediátr Panamá [Internet]. 2017;46(2):112–8. Available from: www.neurometplus.com
BIGUELINI CP. Atenção farmacêutica domiciliar a hipertensos: experiência baseada no método DADER de acompanhamento farmacoterapêutico. Infarma - Ciências Farm. 2013;25(1):51.
Capucho HC. Monitoramento e Avaliação Farmacoterapêutica: o medicamento fez efeito? Qual? Organ Pan-Americana da Saúde/Organização Mund da Saúde [Internet]. 2016;1(20):1–7. Available from: http://lattes.cnpq.br/0079781302123191%0Ahttps://www.paho.org/bra.../index.php?option=com_docman&view=download&category_slug=serie-uso-racional-medicamentos-284&alias=1548-monitoramento-e-avaliacao-farmacoterapeutica-o-medicamento-fez-efeito-qual-8&Itemid
Amarante L, Shoji L, Beijo L, Lourenço E. A influência do acompanhamento farmacoterapêutico na adesão à terapia anti-hipertensiva e no grau de satisfação do paciente. Rev ciênc farm básica apl. 2010;31(3):209–15.